期刊文献+

C反应蛋白定性检测在良恶性胸腹水鉴别诊断中的临床意义 被引量:6

Clinical Value of Qualitative Determination of C-Reactive Protein in the Differential Diagnosis of Benign and Malignant Pleural Effusions or Ascites
下载PDF
导出
摘要 目的:探讨C反应蛋白(C-reactive protein,CRP)定性检测在良恶性胸腹水鉴别诊断中的临床价值。方法:采用胶乳凝集法定性检测3820例患者胸腹水中的CRP,在反应板孔中先后加入标本及胶乳试剂,充分混匀,2 min后观察结果。如肉眼可见凝集颗粒,则为阳性。结果:672例恶性胸腹水标本中CRP阳性率为6.1%,其中32例淋巴造血系统肿瘤患者的胸腹水中CRP阳性率为75.0%,640例上皮性恶性肿瘤患者胸腹水中CRP阳性率为2.7%;3148例良性胸腹水中CRP阳性率为21.8%。良性胸腹水CRP阳性率显著高于恶性胸腹水,淋巴造血系统肿瘤胸腹水CRP阳性率显著高于上皮性恶性肿瘤胸腹水(P<0.01)。结论:CRP定性检测对于鉴别良恶性胸腹水以及鉴别淋巴造血系统肿瘤与上皮性恶性肿瘤胸腹水有一定价值。 Objective:To explore the clinical value of qualitative determination of C-reactive protein (CRP) in the differential diagnosis of benign and malignant pleural effusions or ascites .Methods :CRP in 3820 cases of pleural effusions and ascites were qualitatively examined by latex agglutination method .Specimen and latex reagent were added to the wells of the reaction plate successively .The result was observed after 2 minutes’ thorough mixing .The result was judged as positive if agglutination par-ticles were visible .Results:The positive rate of CRP in 672 cases of malignant pleural effusions and ascites was 6 .1% .The positive rate of CRP in pleural effusions and ascites was 75 .0% in 32 cases of hematopoietic and lymphoid tissue tumors ,and 2 .7% in 640 cases of epithelial malignant tumors .The positive rate of CRP in pleural effusions and ascites in 3148 cases of be-nign diseases was 21 .8% .The positive rate of CRP in benign pleural effusions and ascites was higher than that in malignant pleural effusions and ascites(P〈0 .05) .The positive rate of CRP in pleural effusions and ascites of patients with hematopoietic and lymphoid tumors was higher than that of patients with epithelial malignant tumors .Conclusions :Qualitative determination of CRP in pleural effusions and ascites can be used to differentiate benign and malignant pleural effusions and ascites ,and to differentiate pleural effusions and ascites of hematopoietic and lymphoid tissue tumors and epithelial malignant tumors .
出处 《中国临床医学》 2014年第3期245-246,共2页 Chinese Journal of Clinical Medicine
基金 国家自然科学基金青年科学基金项目(编号:81101809)
关键词 C反应蛋白 淋巴瘤 胸水 腹水 C-reactive Protein Lymphoma Pleural effusions Ascites
  • 相关文献

参考文献3

二级参考文献15

  • 1金雪文,王雪芬.胸液CRP测定鉴别良恶性胸水的临床价值[J].浙江医学,2007,29(2):128-129. 被引量:4
  • 2杨燕,金建树.CRP与LDH的检测在结核性与癌性胸腔积液中的应用[J].实用医技杂志,2004,11(08B):1544-1545. 被引量:9
  • 3黄维周,时昭红,杜敏丽,龚超.C-反应蛋白临床研究进展[J].中国实用内科杂志,1996,16(4):245-246. 被引量:65
  • 4[3]Castano vidrialesJL,A mores Anteguera C.Use of pleural fluidc-reactive protein in laboratory diagnosis of pleural effusion[J].Eur J med,1992,1:201~207.
  • 5[6]Porcel JM,Vires M,Differentiating tuberculous from Malignant Pleural Effussions:a scoring model[J].Medsci Monit,2003,9(5):CR175-180.
  • 6[7]Chung JH,Kim YS,Kim SI,et al.The diagnostic value of the adenosine deam inase activity in pleural fluid of renal transplant patients with tuberculous pleural effusions[J].Yonsei Med J,2004,45(4):661-664.
  • 7[8]Hellbrand DJ,Runyon BA,Pasm ineh WG,et al.Ascitic fluid adenosine deam inase insentivity in detecting tuberculous peritonitis in the United States[J].hepatology,1996,24(6):1408-1413.
  • 8任少华.利用胸水C反应蛋白诊断胸水[J].国外医学:内科学分册,2001,28(3):127-128.
  • 9Constantindes IP, Pathouli C, Karvountzis G, et al. Serum beta-2 mieroglobulin in malignant lymphoproliferative disorders[J]. Cancer, 1985, 55(10) :2384-2389.
  • 10Benbobker L,Valm C, Linassier C, et al. A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA125 and LDH serum levels[J]. Ann Oncol, 2000,11(11) : 1485-1491.

共引文献11

同被引文献64

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部